General - Kidney Stone Disease
Payments companies reported to CMS as associated with General - Kidney Stone Disease. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with General - Kidney Stone Disease, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with General - Kidney Stone Disease
These are the largest totals companies reported as associated with General - Kidney Stone Disease. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| William Roberts | Ann Arbor, MI | Urology | $56,088.15 |
| William Atallah | Brooklyn, NY | Urology | $26,121.78 |
| Hannah Jarvis | Birmingham, AL | $20,000.00 | |
| Thomas Chi | Birmingham, AL | Urology | $13,395.01 |
| Mantu Gupta | New York, NY | $12,296.74 | |
| Marcelino Rivera | Indianapolis, IN | Urology | $12,003.04 |
| Noah Canvasser | Sacramento, CA | Urology | $11,938.98 |
| Nicole Miller | Nashville, TN | Urology | $10,857.87 |
| Mitchell Humphreys | Phoenix, AZ | Urology | $9,382.17 |
| Naveen Kachroo | Detroit, MI | Urology | $7,848.00 |
Prescribed General - Kidney Stone Disease?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.